In conclusion, our study suggests that USP21 plays an important role in the progression of CCA; Therefore, the USP21/HSP90/HIF1A axis and USP21/ENO1 axis may serve as potential targets for molecular-based therapy for CCA. Here, ENO1 is linked to cholangiocarcinoma.